MarketInOut Stock Screener Log In | Sign Up
 

CSL Ltd

OTC • Healthcare • Biotechnology • Quote as of 10/21/2026
CSL Ltd stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeOTC
Market Capitalization58,114 mln
Float480 mln
Earnings Date02/11/2027

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-3.37
Reliable

Relative Strength

81 / 100
Strongly outperforming

Debt / Equity

0.74
Moderate leverage

Pre-Tax Margin

-25%
Deeply loss-making

ROE

-13.81
Negative

Business Description

CSL Limited is a global healthcare company founded in 1916 and based in Melbourne, Australia, that develops and delivers medicines and vaccines to patients across more than a dozen countries. Its three main business units cover a broad range of medical needs, including treatments derived from blood plasma, influenza vaccines supplied to governments worldwide, and medicines that address iron deficiency and kidney-related conditions. The company also pursues gene therapies and licenses its scientific innovations to other organizations.

Key Fundamentals

EPS-5.35
ROE-13.81
RPS32.78
ROIC9.19
ROA-6.58
Interest Cover9.40
EBITDA, mln-2,616
EV / EBITDA-27.54
EV / EBIT-19.70
Revenue, mln15,698
EV / Revenue4.59

Quote Details

Last 136.9000
Change 0.945 (0.7%)
Open 136.9000
Volume 2,609
Turnover 357,172
Average Volume 854

Financial Ratios

Pre-Tax Profit Margin-25
Leverage Ratio2.27
Current Ratio2.21
Price / Book3.71
Price / Tangible Book11.33
Price / Cash Flow18.09
Price / Free Cash Flow21.54
Debt / Equity0.74
Price / Sales3.79

Financial Strength

Altman Z-Score3.01
Piotroski F-Score 4 / 9
Beneish M-Score-3.37
Price to Intrinsic Value1.70
Price to Graham Number3.23
Shiller PE Ratio29.11

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 8.62% 88 / 100   
1 Month 39.65% 97 / 100   
2 Months 79.87% 97 / 100   
6 Months 7.06% 68 / 100   
1 Year -11.99% 39 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog